HomeNewsIndiaIndia, France to work towards setting up Indo-Pacific trilateral development cooperation: EAM

India, France to work towards setting up Indo-Pacific trilateral development cooperation: EAM

France is central to emergence of multi-polarity and has also been extremely responsive to India's concerns and priorities, S Jaishankar said.

September 14, 2022 / 16:47 IST
Story continues below Advertisement
S Jaishankar
S Jaishankar

India and France have agreed to work towards the establishment of an Indo-Pacific trilateral development cooperation that would facilitate development projects, External Affairs Minister S Jaishankar said after talks with his French counterpart Catherine Colonna.

Addressing a joint press interaction alongside Colonna, Jaishankar said their discussions covered issues such as the Ukraine conflict, the tensions in the Indo-Pacific, consequences of the Covid pandemic, developments in Afghanistan and the prospects of the Joint Comprehensive Plan of Action.

Story continues below Advertisement

"We agreed to work towards the establishment of an Indo-Pacific trilateral development cooperation that would facilitate development projects, especially in framework of International Solar Alliance," Jaishankar said.

The ISA now has firmed up projects in three countries which shows the impact India and France make together in Bhutan, Papua New Guinea and Senegal, he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show